Vasopressin
Who holds supplier records for Vasopressin? 8 organisations hold a current record for Vasopressin: an active US FDA Type II Drug Master File. A further 1 organisation has only historical (inactive) DMF filings. Recorded organisation countries for current records: India (2), Spain (1), China (1) and Sweden (1); not recorded for 3.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Vasopressin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/vasopressin
Reading the evidence
- 8 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Vasopressin expires 27 Sept 2044. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (8)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Vasopressin. Country is the organisation's recorded country, not necessarily the manufacturing site.
- AURO PEPTIDES LTDActive DMF 33119 · latest filing Aug 2018
- BACHEM AMERICAS INCActive DMF 28532 · latest filing Aug 2014
- BCN PEPTIDES SASpainActive DMF 25736 · latest filing Jan 2012
- HAINAN SHUANGCHENG PHARMACEUTICALS CO LTDChinaActive DMF 37634 · latest filing Dec 2022
- Hetero Drugs LimitedIndia Company GMP cert on recordActive DMF 42073 · latest filing Jun 2025
- INTERNATIONAL MEDICATION SYSTEMS LTDActive DMF 32769 · latest filing May 2018
- Piramal Pharma LimitedIndia Company GMP cert on recordActive DMF 32146 · latest filing Oct 2017
- PolyPeptide Laboratories (Sweden) ABSweden Company GMP cert on recordActive DMF 32116, 27577 · latest filing Oct 2017
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (1)
Organisations whose Type II DMFs for Vasopressin are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- Netherlands · Inactive DMF 6507 · filed Jul 1986
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (21 listed products contain Vasopressin). The latest listed patent expires 27 Sept 2044. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Vasopressin is a peptide hormone that plays a key role in regulating the body's retention of water and blood pressure. It acts primarily on the kidney's collecting ducts to reabsorb water, thus concentrating urine and increasing blood pressure.
Chemical identity
- IUPAC name
- (2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]pyrrolidine-2-carboxamide
- Canonical SMILES
- C1C[C@H](N(C1)C(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N
- InChIKey
- KBZOIRJILGZLEJ-LGYYRGKSSA-N
- Synonyms
- Pitressin API, 8-l-argininevasopressin, arginine vasopressin, argipressin, hbn-1 component vasopressin, vasopressin, 8-arginine, vasopressin, 8-l-arginine-, vasostrict
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Physiologic effect
- Decreased Diuresis; Vasoconstriction
- Chemical structure
- Vasopressins
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Vasopressin?
8 organisations hold an active US FDA Type II Drug Master File or a CEP for Vasopressin: AURO PEPTIDES LTD, BACHEM AMERICAS INC, BCN PEPTIDES SA (Spain), HAINAN SHUANGCHENG PHARMACEUTICALS CO LTD (China), Hetero Drugs Limited (India), INTERNATIONAL MEDICATION SYSTEMS LTD, Piramal Pharma Limited (India) and PolyPeptide Laboratories (Sweden) AB (Sweden). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Vasopressin Drug Master Files are active?
AURO PEPTIDES LTD (DMF 33119), BACHEM AMERICAS INC (DMF 28532), BCN PEPTIDES SA (DMF 25736), HAINAN SHUANGCHENG PHARMACEUTICALS CO LTD (DMF 37634), Hetero Drugs Limited (DMF 42073), INTERNATIONAL MEDICATION SYSTEMS LTD (DMF 32769), Piramal Pharma Limited (DMF 32146) and PolyPeptide Laboratories (Sweden) AB (DMF 32116, 27577). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Vasopressin records mean?
1 organisation has only inactive Type II DMFs for Vasopressin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does the FDA Orange Book list patents for products containing Vasopressin?
Yes. The latest patent listed for an approved US product containing Vasopressin expires 27 Sept 2044, across 21 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Vasopressin supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Vasopressin?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.